Gadgeel SM, Rodriguez-Abreu D, Halmos B, Garassino MC, et al. Pembrolizumab Plus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After 5 Years of Follow-Up. J Thorac Oncol 2024 Apr 18:S1556-0864(24)00169.
PMID: 38642841